S. Alfandari

4.0k total citations
112 papers, 2.1k citations indexed

About

S. Alfandari is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, S. Alfandari has authored 112 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 37 papers in Infectious Diseases and 20 papers in Applied Microbiology and Biotechnology. Recurrent topics in S. Alfandari's work include Antibiotic Use and Resistance (20 papers), Nosocomial Infections in ICU (16 papers) and Pneumonia and Respiratory Infections (16 papers). S. Alfandari is often cited by papers focused on Antibiotic Use and Resistance (20 papers), Nosocomial Infections in ICU (16 papers) and Pneumonia and Respiratory Infections (16 papers). S. Alfandari collaborates with scholars based in France, United States and United Kingdom. S. Alfandari's co-authors include O. Leroy, Hugues Georges, Benoît Guéry, G. Beaucaire, Y Mouton, Patrick Devos, Nicolas Boussekey, Stéphane de Botton, M. Valette and H. Portier and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

S. Alfandari

107 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Alfandari France 22 1.0k 951 344 245 238 112 2.1k
Virginia Roth Canada 28 572 0.6× 920 1.0× 312 0.9× 224 0.9× 189 0.8× 72 2.2k
Christian Ruef Switzerland 21 690 0.7× 827 0.9× 236 0.7× 321 1.3× 200 0.8× 45 2.0k
Philip Toltzis United States 23 673 0.6× 655 0.7× 327 1.0× 177 0.7× 185 0.8× 86 1.6k
Angelo Pan Italy 24 550 0.5× 1.1k 1.1× 173 0.5× 101 0.4× 409 1.7× 69 2.2k
Wato Nsa United States 19 1.0k 1.0× 491 0.5× 262 0.8× 116 0.5× 132 0.6× 32 2.0k
Sigfrido Rangel-Frausto Mexico 13 629 0.6× 511 0.5× 294 0.9× 210 0.9× 100 0.4× 35 1.4k
M. M. E. Schneider Netherlands 20 934 0.9× 774 0.8× 278 0.8× 78 0.3× 68 0.3× 39 1.7k
Francisc Schlaeffer Israel 24 735 0.7× 429 0.5× 125 0.4× 90 0.4× 224 0.9× 80 2.0k
José Bordón United States 24 1.3k 1.3× 376 0.4× 196 0.6× 234 1.0× 147 0.6× 69 2.1k
Anastasia Antoniadou Greece 34 1.3k 1.3× 1.1k 1.1× 189 0.5× 150 0.6× 602 2.5× 124 3.7k

Countries citing papers authored by S. Alfandari

Since Specialization
Citations

This map shows the geographic impact of S. Alfandari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Alfandari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Alfandari more than expected).

Fields of papers citing papers by S. Alfandari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Alfandari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Alfandari. The network helps show where S. Alfandari may publish in the future.

Co-authorship network of co-authors of S. Alfandari

This figure shows the co-authorship network connecting the top 25 collaborators of S. Alfandari. A scholar is included among the top collaborators of S. Alfandari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Alfandari. S. Alfandari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Septfons, Alexandra, et al.. (2024). Freshwater sports and infectious diseases: A narrative review. Infectious Diseases Now. 54(4S). 104883–104883. 1 indexed citations
2.
Fréalle, Émilie, et al.. (2022). A case of subacute bowel obstruction revealing slowly-evolutive gastro-intestinal mucormycosis following allogeneic hematopoietic cell transplantation. Journal de Mycologie Médicale. 32(4). 101312–101312. 3 indexed citations
3.
Alfandari, S., et al.. (2022). Clinical Decision Support Systems for Antibiotic Prescribing: An Inventory of Current French Language Tools. Antibiotics. 11(3). 384–384. 9 indexed citations
4.
Faure, Emmanuel, Hélène Behal, Micha Srour, et al.. (2022). The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients. Blood Advances. 7(5). 856–865. 9 indexed citations
5.
Daniau, Côme, S. Alfandari, C. Dumartin, et al.. (2022). Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France. Infectious Diseases Now. 52(7). 396–402. 1 indexed citations
6.
Gavazzi, G., E. Forestier, Claire Roubaud‐Baudron, et al.. (2022). Explicit definitions of potentially inappropriate prescriptions of antibiotics in hospitalized older patients. Infectious Diseases Now. 52(4). 214–222. 3 indexed citations
7.
Fréalle, Émilie, Hélène Demarquette, Charles Herbaux, et al.. (2021). Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma. Clinical Lymphoma Myeloma & Leukemia. 21(6). e545–e547. 3 indexed citations
8.
Michallet, Mauricette, Mohamad Sobh, Gilbert Deray, et al.. (2020). Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts. Clinical Lymphoma Myeloma & Leukemia. 21(1). 35–45. 5 indexed citations
9.
Leport, Catherine, et al.. (2019). Low to medium-low risk perception for dengue, chikungunya and Zika outbreaks by infectious diseases physicians in France, Western Europe. BMC Public Health. 19(1). 1014–1014. 7 indexed citations
10.
Launay‐Vacher, Vincent, Alexandre Bleibtreu, Perrine Bortolotti, et al.. (2019). Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice. Médecine et Maladies Infectieuses. 50(4). 323–331. 20 indexed citations
11.
Robineau, Olivier, J. Robert, Christian Rabaud, et al.. (2018). Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey). Infection and Drug Resistance. Volume 11. 1359–1368. 22 indexed citations
12.
Robert, J., Y. Péan, S. Alfandari, et al.. (2017). Application of guidelines for aminoglycosides use in French hospitals in 2013–2014. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1083–1090. 7 indexed citations
13.
Alfandari, S., J. Robert, Y. Péan, et al.. (2015). Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study. Médecine et Maladies Infectieuses. 45(11-12). 475–480. 16 indexed citations
14.
Hansmann, Yves, Nicolas Lefèbvre, Matthieu Revest, et al.. (2014). Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease. Médecine et Maladies Infectieuses. 44(5). 199–205. 9 indexed citations
15.
Timsit, Jean‐François, Lila Bouadma, Olivier Mimoz, et al.. (2013). Jugular versus Femoral Short-Term Catheterization and Risk of Infection in Intensive Care Unit Patients. Causal Analysis of Two Randomized Trials. American Journal of Respiratory and Critical Care Medicine. 188(10). 1232–1239. 43 indexed citations
16.
Boussekey, Nicolas, Patrick Devos, S. Alfandari, et al.. (2012). Survival in critically ill patients with acute kidney injury treated with early hemodiafiltration. The International Journal of Artificial Organs. 35(12). 1039–1046. 9 indexed citations
17.
Boussekey, Nicolas, S. Alfandari, Patrick Devos, et al.. (2010). Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Critical Care. 14(2). R40–R40. 33 indexed citations
18.
Alfandari, S., O. Leroy, Stéphane de Botton, et al.. (2005). Prise en charge diagnostique et thérapeutique des infections à Aspergillus sp. chez le patient immunodéprimé. Recommandations du CHRU de Lille — version 4 — novembre 2004. Médecine et Maladies Infectieuses. 35(3). 121–134. 15 indexed citations
19.
Yazdanpanah, Yazdan, Geneviève Chêne, Elena Losina, et al.. (2001). Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. International Journal of Epidemiology. 30(4). 864–871. 55 indexed citations
20.
Alfandari, S., et al.. (2001). Exchange Transfusion for Severe Malaria. Infection. 29(2). 96–97. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Roth Breakdown of academic impact, for papers by Christian Ruef Breakdown of academic impact, for papers by Philip Toltzis Breakdown of academic impact, for papers by Angelo Pan Breakdown of academic impact, for papers by Wato Nsa Breakdown of academic impact, for papers by Sigfrido Rangel-Frausto Breakdown of academic impact, for papers by M. M. E. Schneider Breakdown of academic impact, for papers by Francisc Schlaeffer Breakdown of academic impact, for papers by José Bordón Breakdown of academic impact, for papers by Anastasia Antoniadou
Rankless by CCL
2026